MareaTX is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. The company leverages a proprietary drug discovery platform to identify and advance novel therapeutic candidates for conditions such as Alzheimer's disease.

MareaTX

Le Bernardin is a restaurant that offers a variety of dining options including a dining room, lounge, and private dining services.

Le Bernardin

We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives. THE THIRD ROCK TEAMOur team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to succeed. A FORMULA FOR INNOVATION We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence.We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices and diagnostics. By creating value for patients, we create value for our investors.

Global Blood Therapeutics

Voyager Therapeutics

Larimar Therapeutics

Revolution Medicines

Rhythm Pharmaceuticals

SAGE Therapeutics

Bluebird Bio

Kala Pharmaceuticals

Nurix Therapeutics

Blueprint Medicines

Tango Therapeutics

Magenta Therapeutics

Thrive Earlier Detection

Constellation Pharmaceuticals

CytomX Therapeutics

Editas Medicine

Foundation Medicine

Fulcrum Therapeutics

Pliant Therapeutics

Relay Therapeutics

Third Rock Ventures

Metric
Company Name	MareaTX	Le Bernardin
Symbol
MSH ID	COM:MAREATX	COM:LE-BERNARDIN
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Consumer Services
Industry	Biotechnology	Food and Beverage
Country	US	US
Stage
Employee Count	137
Website	mareatx.com	le-bernardin.com
LinkedIn	third-rock-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	49.99
28-Day Growth Score	14.20
90-Day Growth Score	8.18
365-Day Growth Score	58.35

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MAREATX

MareaTX

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue